ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Delonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of its Innovative Synthetic Vaccines
March 12, 2021Delonix Bioworks Ltd., a biotechnology company dedicated to developing the next generation vaccines with synthetic biology approaches, has recently closed a $14 million Series Seed financing led by Boehringer Ingelheim Venture Fund (BIVF) and IDG ...
Pharma Sources Insight January 2025
